Innovations Stem Cell Center, recently named the top U.S. stem-cell therapy provider by Life Sciences Review, offers patients a safe, standardized, and affordable alternative to unregulated overseas ...
Austin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Cell Banking Outsourcing Market Size & Growth Analysis: According to SNS Insider, the Cell Banking Outsourcing Market is valued at USD 12.5 billion in 2023 ...
Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies are working hard to make advancements that can help patients. Stem cells ...
Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...
Detailed price information for Cryo-Cell Intl Inc (CCEL-A) from The Globe and Mail including charting and trades.
Los Angeles Firm Pelage Pharmaceuticals Raises $120 Million Series B Round for Hair Growth Treatment
Los Angeles biotech firm Pelage Pharmaceuticals raises a $120 million Series B round co-led by ARCH Venture Partners and ...
Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about ...
Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.
The Company uses the following handle on X at @ApolloBioKOAN to communicate with its shareholders About Apollo Biowellness, Inc.
Cordlife Group announced in an Oct 13 bourse filing that it had applied to MOH on Oct 6 for an extension, and the ministry informed it on Oct 12 that the extension had been granted. It now has until ...
Amid a slew of secondary equity raisings and at least two planned IPOs, the biotech sector is ending a difficult year on a ...
The Concerned Shareholder has requisitioned the Meeting because he believes the foregoing issues demonstrate a failure of Board independence, governance accountability and fiduciary oversight which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results